articleNatureNov 25, 2014Closed access

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Institut Gustave Roussy · Harvard University · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,416
total citations
FWCI
147.37
Percentile
100%
References
29
Citations per year

Authors

15

Topics & keywords

Keywords
  • Immune system
  • Immunotherapy
  • Antibody
  • Bladder cancer
  • Monoclonal antibody
  • Medicine
  • Cancer
  • Cancer research
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.